일루미나(ILMN)는 NASDAQ에 상장된 Healthcare · Diagnostics & Research 기업입니다. 현재가 $239.62 (-2.27%), 시가총액 $21.57B, PER (주가수익비율) 25.92, 52주 최저~최고 $79.37 ~ $153.95.
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic inst
일루미나의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.
일루미나의 현재 주가는 $239.62 (-2.27%)입니다. BlackAll Trade에서 실시간 시세와 차트를 확인할 수 있습니다.
일루미나의 시가총액은 약 $21.57B입니다. PER은 25.92입니다.
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers